Product Pipeline

Probuphine®

for the treatment of Opioid Addiction

Market completed
Market completed
Market completed
Market completed
Market in progress
Preclinical Phase 1 Phase 2 Phase 3 Market
More About Probuphine®

Product Pipeline

Ropinirole Implant

for the treatment of Parkinson's Disease

Preclinical in progress
Preclinical not started
Preclinical not started
Preclinical not started
Preclinical not started
Preclinical Phase 1 Phase 2 Phase 3 Market
More About Ropinirole Implant

Product Pipeline

T3 Implant

for the treatment of Hypothyroidism

Preclinical in progress
Preclinical not started
Preclinical not started
Preclinical not started
Preclinical not started
Preclinical Phase 1 Phase 2 Phase 3 Market
More About T3 Implant

About

Titan Pharmaceuticals

Titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long-term, continuous drug delivery platform, ProNeura.

More About Titan Pharmaceuticals

Proneura™

Read an article by Fortune and watch Chief Development Officer Dr. Kate Beebe explain the advantages of the ProNeura long-term continuous drug delivery platform.

Visit Fortune

Watch the Mechanism of Action video for the ProNeura technology platform and learn how continuous drug release maintains stable blood levels of medication to help treat chronic diseases.

Watch MOA Video

Information for

Investors

Titan Pharmaceuticals, Inc. NASDAQ: TTNP
Volume
Day Low/High
52-Week Low/High
Average Volume
Market Cap